Gilead Sciences, Inc. Profile Avatar - Palmy Investing

Gilead Sciences, Inc.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada,…

Drug Manufacturers - General
US, Foster City [HQ]

Lobbying Analysis

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
2023 4 $6,000,000 LD-2 : 01/19/24
2023 4 $7,500,000 LD-2 : 01/18/24
2023 4 $8,000,000 LD-2 : 01/18/24
2023 4 $8,000,000 LD-2 : 01/17/24
2023 4 $5,000,000 LD-2 : 01/13/24

Get PRO Today

With PRO you will unlock 18 more lobbying disclosures for Gilead Sciences, Inc.

End of GILD's Analysis
CIK: 882095 CUSIP: 375558103 ISIN: US3755581036 LEI: - UEI: -
Secondary Listings